Cargando…

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder. Current targeted therapies designed to inhibit the tyrosine kinase activity of the BCR-ABL oncoprotein have made a significant breakthrough in the treatment of CML patients. However, CML remains a chronic disease that a patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamad, Ahmad, Sahli, Zeyad, El Sabban, Maya, Mouteirik, Maha, Nasr, Rihab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725740/ https://www.ncbi.nlm.nih.gov/pubmed/23935640 http://dx.doi.org/10.1155/2013/724360

Ejemplares similares

Validation of a Drosophila model of wild-type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: an effective platform for treatment screening
por: Outa, Amani Al, et al.
Publicado: (2020)

Chronic myeloid leukemia stem cells: targeting therapeutic implications
por: Mojtahedi, Hanieh, et al.
Publicado: (2021)

Therapeutic Challenges in Chronic Myeloid Leukemia: A Case-Based Discussion
por: Perez, Ariel, et al.
Publicado: (2020)

Chronic myeloid leukemia stem cells
por: Houshmand, Mohammad, et al.
Publicado: (2019)

Leukemia stem cells: the root of chronic myeloid leukemia
por: Zhou, Hong, et al.
Publicado: (2015)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Therapeutic use of Aldara™ in chronic myeloid leukemia
por: Marleau, Annette M, et al.
Publicado: (2007)

Acute Myeloid Leukemia: Focus on Novel Therapeutic Strategies
por: Lin, Tara L., et al.
Publicado: (2012)

Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
por: Böhme, Matthias, et al.
Publicado: (2021)

New Therapeutic Strategies for Adult Acute Myeloid Leukemia
por: Ishii, Hiroto, et al.
Publicado: (2022)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
por: Qing, Yingjie, et al.
Publicado: (2021)

Chronic Myeloid Leukemia Stem Cell Biology
por: Crews, Leslie A., et al.
Publicado: (2012)

Stem Cell Biomarkers in Chronic Myeloid Leukemia
por: Jiang, Xiaoyan, et al.
Publicado: (2008)

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2010)

Expression of chronic myeloid leukemia oncogenes BCR-ABL (P210) and BCR-ABL (T315I) affect cellular and humoral innate immunity in Drosophila melanogaster
por: Abubaker, Dana, et al.
Publicado: (2022)

Molecular signatures of chronic myeloid leukemia stem cells
por: Chen, Yaoyu, et al.
Publicado: (2013)

The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients
por: Park, Moon Nyeo
Publicado: (2023)

A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology
por: Skayneh, Hala, et al.
Publicado: (2019)

RhoA: A therapeutic target for chronic myeloid leukemia
por: Molli, Poonam R, et al.
Publicado: (2012)

The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia
por: Wu, Andrew, et al.
Publicado: (2023)

Re-emergence of interferon-α in the treatment of chronic myeloid leukemia
por: Talpaz, M, et al.
Publicado: (2013)

HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
por: Losson, Hélène, et al.
Publicado: (2020)

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
por: Hehlmann, Rüdiger, et al.
Publicado: (2022)

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies
por: El Achi, Hanadi, et al.
Publicado: (2021)

Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
por: Xiao, Yan, et al.
Publicado: (2023)

Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate
por: Das, Andrew B., et al.
Publicado: (2020)

Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies
por: Guarnera, Luca, et al.
Publicado: (2023)

Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia
por: Parting, Oliver, et al.
Publicado: (2020)

Chronic myeloid leukemia
por: Hantschel, Oliver
Publicado: (2019)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
por: Houshmand, Mohammad, et al.
Publicado: (2021)

ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression
por: El-Saghir, Jamal, et al.
Publicado: (2016)

Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis
por: Adel, Ahmad, et al.
Publicado: (2021)

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008)

B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
por: Yohannan, Binoy, et al.
Publicado: (2022)

Emergence of chronic myeloid leukemia following autologous stem cell transplantation in a young woman with multiple myeloma
por: Barrett, Aisling, et al.
Publicado: (2018)

Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia
por: Haslam, Sonya
Publicado: (2005)

Emergency therapeutic leukapheresis in a case of acute myeloid leukemia M5
por: Ranganathan, Sudha, et al.
Publicado: (2008)

Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia
por: Aziz, Habsah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ruqdutbd9hsouu1f4sfsuv0olp